Johnson & Johnson plans to test its covid-19 vaccine in ages 12-18 soon

J&J said in a statement that it is currently in discussions with regulators and partners regarding the inclusion of the pediatric population in its trials.J&J started testing the vaccine in adults in a 60,000-volunteer Phase III study in late September

Read the full article here

Related Articles